HSBC Holdings’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3K | Sell |
15,830
-70,771
| -82% | -$90.6K | ﹤0.01% | 2500 |
|
|
2025
Q1 | $100K | Sell |
86,601
-208
| -0.2% | -$240 | ﹤0.01% | 2353 |
|
|
2024
Q4 | $154K | Buy |
86,809
+8,106
| +10% | +$14.4K | ﹤0.01% | 2366 |
|
|
2024
Q3 | $137K | Sell |
78,703
-419
| -0.5% | -$728 | ﹤0.01% | 2348 |
|
|
2024
Q2 | $106K | Buy |
79,122
+32,899
| +71% | +$43.9K | ﹤0.01% | 2353 |
|
|
2024
Q1 | $173K | Sell |
46,223
-30,757
| -40% | -$115K | ﹤0.01% | 2318 |
|
|
2023
Q4 | $759K | Buy |
76,980
+47,600
| +162% | +$469K | ﹤0.01% | 1495 |
|
|
2023
Q3 | $242K | Buy |
+29,380
| New | +$242K | ﹤0.01% | 1840 |
|
|
2022
Q3 | – | Sell |
-95,454
| Closed | -$422K | – | 2684 |
|
|
2022
Q2 | $422K | Sell |
95,454
-1,499
| -2% | -$6.63K | ﹤0.01% | 2042 |
|
|
2022
Q1 | $883K | Buy |
96,953
+53,919
| +125% | +$491K | ﹤0.01% | 1712 |
|
|
2021
Q4 | $880K | Hold |
43,034
| – | – | ﹤0.01% | 1705 |
|
|
2021
Q3 | $1.1M | Buy |
43,034
+32,639
| +314% | +$834K | ﹤0.01% | 1444 |
|
|
2021
Q2 | $364K | Buy |
+10,395
| New | +$364K | ﹤0.01% | 1981 |
|
|
2021
Q1 | – | Sell |
-15,567
| Closed | -$405K | – | 2529 |
|
|
2020
Q4 | $405K | Buy |
+15,567
| New | +$405K | ﹤0.01% | 1932 |
|
|
2020
Q3 | – | Sell |
-42,672
| Closed | -$147K | – | 2327 |
|
|
2020
Q2 | $147K | Buy |
42,672
+16,837
| +65% | +$58K | ﹤0.01% | 2063 |
|
|
2020
Q1 | $79K | Buy |
25,835
+12,753
| +97% | +$39K | ﹤0.01% | 2084 |
|
|
2019
Q4 | $69K | Sell |
13,082
-882,204
| -99% | -$4.65M | ﹤0.01% | 2400 |
|
|
2019
Q3 | $4.62M | Buy |
895,286
+29,328
| +3% | +$151K | 0.01% | 813 |
|
|
2019
Q2 | $5.24M | Buy |
+865,958
| New | +$5.24M | 0.01% | 788 |
|
|
2017
Q1 | – | Sell |
-13,836
| Closed | -$53K | – | 1965 |
|
|
2016
Q4 | $53K | Buy |
+13,836
| New | +$53K | ﹤0.01% | 2215 |
|